Lipocine Inc. buy Maxi_Scalibusa
Start price
21.01.21
/
50%
€32.30
Target price
21.01.22
€136.00
Performance (%)
-57.58%
End price
22.01.22
€13.70
Summary
This prediction ended on 22.01.22 with a price of €13.70. The BUY prediction by Maxi_Scalibusa for Lipocine Inc. performed very badly with a performance of -57.58%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Lipocine Inc. | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
According to Maxi_Scalibusa what are the pros and cons of Lipocine Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Lipocine Inc diskutieren
In the thread Trading Lipocine Inc
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten